StonvexLoading…
StonvexStonvexStonvexCore line items from RL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-27 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 | Annual 2025 2025-03-29 |
|---|---|---|---|---|
Revenue | $6.14B | $3.73B | $1.72B | $7.08B |
Operating Income | $990.60M | $519.30M | $273.60M | $932.10M |
Net Income | $789.50M | $427.90M | $220.40M | $742.90M |
EPS (Diluted) | $12.66 | $6.85 | $3.52 | $11.61 |
Total Assets | $7.81B | $7.35B | $7.75B | $7.05B |
Total Liabilities | $4.93B | $4.77B | $5.24B | $4.46B |
Cash & Equivalents | $2.03B | $1.44B | $2.09B | $1.92B |
Free Cash Flow OCF − CapEx | $652.20M | $-51.80M | $-11.20M | $1.02B |
Shares Outstanding | 62.40M | 62.50M | 62.50M | 64.00M |